Medicines for influencing the posttranslational modifications of histones – a tutorial review
De Remediis · 2024
DOI: 10.71116/2rks7z60 ↗Kurz gefasst
Fachartikel in der Zeitschrift De Remediis, 2024. Verfasst von Miklós Bege und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epigenetic therapy is a relatively novel, but undoubtedly a promising area of pharmacology. Most epigenetic drugs act by affecting enzymes and play a role in post-translational modifications of histones. The molecular targets of these medicines include histone methyltransferases, histone demethylases, isocitrate dehydrogenases, histone acetyltransferases and histone deacetylases. Since histone modifications are important regulatory signals, abnormalities in this process often lead to tumorigenesis, therefore these medicines constitute an important class of antitumor therapy. In this tutorial review, we would like to briefly overview the medicines that affect histone modifications, focusing on the currently approved ones, and briefly mention other interesting examples.
Zitieren
APA
Bege, M., & Borbás, A. (2024). Medicines for influencing the posttranslational modifications of histones – a tutorial review. De Remediis. https://doi.org/10.71116/2rks7z60
Vancouver
Bege M, Borbás A. Medicines for influencing the posttranslational modifications of histones – a tutorial review. De Remediis. 2024. doi:10.71116/2rks7z60
BibTeX
@article{Bege2024,
author = {Bege, Miklós and Borbás, Anikó},
title = {Medicines for influencing the posttranslational modifications of histones – a tutorial review},
journal = {De Remediis},
year = {2024},
doi = {10.71116/2rks7z60}
}
EUVIMED